Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo
Peter Clark, Fiona Jordan(1), Charles Pearson(2), Isobel D.Walker(2), Naveed Sattar(1), Joanne Ellison(1), Ian A.Greer(1)
(1)University Department of Obstetrics and Gynaecology, (2)Department of Haematology, Royal Infirmary, Glasgow, Scotland, UK. Department of Transfusion Medicine, Ninewells Hospital, Dundee, Scotland, UK
Summary
Monocytes play a pivotal role in both the inflammatory andcoagulation responses, which may be mediated through avariety of adhesion molecules on the cell surface, includingintercellular adhesion molecule-1 (ICAM-1). Monocytes alsopossess thrombin receptors. In the current study,we have demonstratedthat thrombin can upregulate ICAM-1 mRNA andinduce ICAM-1 expression on the monocyte in vitro and that, invivo, higher monocyte ICAM-1 expression is observed in pregnancy(which is characterised by a physiological increase inthrombin generation). In pregnant subjects, a positive correlationbetween monocyte ICAM-1 expression and a number ofmarkers of vascular/thrombotic disease (including blood group, acquired activated protein C resistance and non-fasting plasmatriglyceride levels) was observed.We also observed a significantrelationship between monocyte ICAM-1 expression and solubleplasma ICAM-1 levels, which would be consistent with acontribution of monocytic ICAM-1 to the levels of free ICAM-1 observed in plasma during pregnancy.Consistent with a role in fibrinogen binding, our preliminaryin vivo results suggest that monocyte ICAM-1 expression maybe a useful marker of the thrombotic/inflammatory response,although further work is required to assess the relationship ofmonocyte ICAM-1 expression in thrombotic disorders.